Implantable cardioverter defibrillator having a smaller mass
First Claim
1. An implantable cardioverter defibrillator for subcutaneous positioning within a pectoral region of a human patient comprising:
- a sealed housing structure constructed of a biocompatible material;
a battery source of electrical energy contained in the housing;
a capacitor system connected to the battery source wherein the capacitor system stores electrical energy provided by the battery source to generate high voltage electrical cardioversion/defibrillation countershocks; and
a control system connected to the capacitor system to control the storing of the electrical energy in the capacitor system and to control the discharge of the electric energy in the capacitor systems; and
wherein a total mass of the implantable cardioverter defibrillator is less than about 120 grams.
1 Assignment
0 Petitions
Accused Products
Abstract
A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller mass of less than about 120 grams. The smaller mass of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (Ipe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current Ipe, there is a significant decrease in the maximum electrical charge energy (Ec) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum Ec, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 μF. By optimizing both the charging time and the countershock duration for the smaller maximum Ec, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.
430 Citations
7 Claims
-
1. An implantable cardioverter defibrillator for subcutaneous positioning within a pectoral region of a human patient comprising:
-
a sealed housing structure constructed of a biocompatible material; a battery source of electrical energy contained in the housing; a capacitor system connected to the battery source wherein the capacitor system stores electrical energy provided by the battery source to generate high voltage electrical cardioversion/defibrillation countershocks; and a control system connected to the capacitor system to control the storing of the electrical energy in the capacitor system and to control the discharge of the electric energy in the capacitor systems; and wherein a total mass of the implantable cardioverter defibrillator is less than about 120 grams. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification